about
Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatmentNovel potent pyridoxine-based inhibitors of AChE and BChE, structural analogs of pyridostigmine, with improved in vivo safety profile.Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment.Nanoparticle-Delivered 2-PAM for Rat Brain Protection against Paraoxon Central Toxicity.C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: Pharmacokinetic and pharmacodynamic studies.6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.6-Methyluracil Derivatives as Bifunctional Acetylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease.Luminescent silica nanoparticles for sensing acetylcholinesterase-catalyzed hydrolysis of acetylcholine.Study of hepatoprotective effects of xymedon.Combination delivery of two oxime-loaded lipid nanoparticles: Time-dependent additive action for prolonged rat brain protectionWater structure changes in oxime-mediated reactivation process of phosphorylated human acetylcholinesteraseThe influence of the Xymedon preparation (Hydroxyethyldimethyldihydropyrimidine) on the rat liver recovery under toxic damage induced by carbon tetrachlorideMixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model
P50
Q27704207-7FE67B3A-28C8-435F-ABCA-05D8DC544B50Q36067674-397EDE27-7297-4360-85C1-342D34081CF6Q47561172-337880C9-D8F8-4A37-996C-F1A17CF33944Q48144083-6ACE9F44-517F-416C-97F0-2450B2DA8C47Q49579654-2C69D32B-79A1-467E-B044-F16C6DDCB67EQ50545970-6D7207F7-7771-4B31-84E8-EC363120EFA6Q50705887-F4FB8D77-2F5A-4006-A474-F0756D605307Q53459012-8CC35677-D7FA-4AA8-A115-D10E00833F0CQ54518179-05AA1F39-B5C7-42CC-9100-C0E7640D6EC5Q57294739-53A1EB8E-E72A-40CA-BE48-0AF432EAE663Q60648567-5CCB837C-0E8D-4D31-80F9-F119A8B1F7B9Q85572368-A71F23D8-E7A3-4EC4-A742-A4319B44451FQ90614010-341C2631-30FF-44F2-BC86-9F61A6849009
P50
description
researcher ORCID ID = 0000-0002-0518-0384
@en
wetenschapper
@nl
name
Irina V Zueva
@ast
Irina V Zueva
@en
Irina V Zueva
@nl
type
label
Irina V Zueva
@ast
Irina V Zueva
@en
Irina V Zueva
@nl
prefLabel
Irina V Zueva
@ast
Irina V Zueva
@en
Irina V Zueva
@nl
P31
P496
0000-0002-0518-0384